Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)

CNY 12.25

(4.08%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 12.46 Billion 11.67 Billion 11.5 Billion 10.23 Billion 9.01 Billion 8.18 Billion
Total Current Assets 7.16 Billion 6.38 Billion 6.67 Billion 6 Billion 5.76 Billion 5.21 Billion
Cash And Short Term Investments 1.45 Billion 1 Billion 1.55 Billion 1.53 Billion 2.55 Billion 2.25 Billion
Cash and Cash Equivalents 1.45 Billion 1 Billion 1.55 Billion 1.53 Billion 2.55 Billion 2.25 Billion
Short Term Investments 427.02 Thousand 505.08 Thousand -812.02 Million -799.53 Million -1.07 Billion -57.52 Million
Net Receivables 4.73 Billion 4.11 Billion 4.17 Billion 3.36 Billion 2.32 Billion 1.5 Billion
Inventory 720.88 Million 1 Billion 733.26 Million 959.54 Million 720.33 Million 1.21 Billion
Other Current Assets 256.4 Million 263.18 Million 211.71 Million 140.07 Million 171.26 Million 241.07 Million
Total Non-Current Assets 5.29 Billion 5.29 Billion 4.83 Billion 4.23 Billion 3.25 Billion 2.96 Billion
Net PPE 1.42 Billion 1.46 Billion 1.45 Billion 1.46 Billion 1.55 Billion 2.44 Billion
Good Will And Intangible Assets 1 Billion 980 Million 367.2 Million 272.81 Million 262.54 Million 250.07 Million
Good Will 14.82 Million 17.22 Million 18.5 Million 18.5 Million 16.1 Million 16.1 Million
Intangible Assets 994.34 Million 962.78 Million 348.7 Million 254.31 Million 246.44 Million 233.97 Million
Long-Term Investments 1.26 Billion 1.22 Billion 2.04 Billion 1.65 Billion 1.31 Billion 118.17 Million
Tax Assets 302.59 Million 239.98 Million 159.22 Million 149.89 Million 115.11 Million 127.93 Million
Other Non Current Assets 1.29 Billion 1.38 Billion 800.69 Million 691.42 Million 8.65 Million 25.59 Million
Other Assets 1.00 - 1.00 1.00 - 1.00
Total Liabilities 4.42 Billion 4.56 Billion 4.45 Billion 4.73 Billion 3.76 Billion 3.19 Billion
Total Current Liabilities 2.75 Billion 3.86 Billion 2.81 Billion 2.25 Billion 2.4 Billion 2.84 Billion
Account Payables 332.98 Million 806.24 Million 797 Million 581.33 Million 249.65 Million 181.67 Million
Tax Payables 121.44 Million 198.91 Million 64.23 Million 137 Million 99.46 Million 102.28 Million
Short Term Debt 1.85 Billion 2.45 Billion 1.65 Billion 1.07 Billion 1.55 Billion 1.97 Billion
Deferred Revenue 491.8 Million 54.96 Million 304.51 Million 492.87 Million 574.22 Million 102.28 Million
Other Current Liabilities 77.67 Million 549.22 Million 59.57 Million 103.97 Million 22.72 Million 589.64 Million
Total Non Current Liabilities 1.67 Billion 701.88 Million 1.64 Billion 2.47 Billion 1.36 Billion 355.04 Million
Long-Term Debt 1.29 Billion 469.95 Million 1.29 Billion 2.13 Billion 1.13 Billion 180 Million
Deferred Revenue Non Current 169.34 Million 181.88 Million 197.24 Million 197.08 Million 157.65 Million 152.92 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 176.57 Million 46.37 Million 150.42 Million 147.91 Million 78.32 Million 22.11 Million
Other Liabilities 1.00 1.00 1.00 1.00 1.00 -
Total Equity 8.04 Billion 7.1 Billion 7.05 Billion 5.5 Billion 5.25 Billion 4.98 Billion
Stock Holders Equity 7.54 Billion 7.09 Billion 7.04 Billion 5.49 Billion 5.24 Billion 4.97 Billion
Common Stock 941.96 Million 941.96 Million 941.96 Million 849.16 Million 849.16 Million 849.16 Million
Retained Earnings 3.8 Billion 3.36 Billion 3.3 Billion 2.99 Billion 2.81 Billion 2.55 Billion
Accumulated other comprehensive income 3.93 Million 474.18 Million 450.16 Million 426.13 Million 356.21 Million 340.44 Million
Common Stock Equity 7.54 Billion 7.09 Billion 7.04 Billion 5.49 Billion 5.24 Billion 4.97 Billion
Capital Lease Obligation 138.35 Thousand 9.95 Million 3.53 Million 6.1 Million - -
Total Investments 1.26 Billion 1.22 Billion 1.23 Billion 859.64 Million 243.96 Million 60.65 Million
Total Debt 3.15 Billion 2.92 Billion 2.94 Billion 3.2 Billion 2.68 Billion 2.15 Billion
Net Debt 1.69 Billion 1.92 Billion 1.39 Billion 1.66 Billion 132.13 Million -104.86 Million

Balance Sheet Charts